Morgan Stanley analyst Jeffrey Hung upgrades Esperion Therapeutics (NASDAQ:ESPR) from Underweight to Equal-Weight and announces $9 price target.
Dow Turns Higher; Oracle Shares Tumble After Q1 Results
U.S. stocks traded mixed midway through trading, with the Dow Jones turning higher on Tuesday.
The Dow traded up 0.22% to 34,740.15 while the NASDAQ fell 0.55% to 13,841.02. The S&P 500, also fell, dropping, 0.24% to 4,476.51.
